Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial. Issue 10 (October 2019)

Record Type:: Journal Article
Title:: Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial. Issue 10 (October 2019)
Main Title:: Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial
Authors:: Sweet, Kristen
Dasgupta, Bidisha
de Vries, Dick
Gourley, Ian
Hsu, Benjamin
Loza, Matthew J
Taylor, Peter C
Abstract:
Is Part Of:: Annals of the rheumatic diseases. Volume 78:Issue 10(2019)
Journal:: Annals of the rheumatic diseases
Issue:: Volume 78:Issue 10(2019)
Issue Display:: Volume 78, Issue 10 (2019)
Year:: 2019
Volume:: 78
Issue:: 10
Issue Sort Value:: 2019-0078-0010-0000
Page Start:: 1439
Page End:
Publication Date:: 2019-10
Subjects:: rheumatoid arthritis -- ultrasonography -- dmards (biologic)
Rheumatism -- Periodicals
616.723005
Journal URLs:: http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗
DOI:: 10.1136/annrheumdis-2019-215183 ↗
Languages:: English
ISSNs:: 0003-4967
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 22980.xml